Physician profile
Daniel Kurz
NPI 1922530328
$339.45
in general payments reported to CMS, 2019-2025
9 companies · $83.66 in 2025
The $83.66 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.43 · 2022: $61.53 · 2023: $128 · 2024: $38.54 · 2025: $83.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $116.17 | 2022-2025 | Ozempic, Rybelsus |
| Laborie Medical Technologies Corp. | $38.54 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $37.00 | 2023 | |
| Almatica Pharma LLC | $31.57 | 2025 | Teriparatide |
| Astrazeneca Pharmaceuticals LP | $30.91 | 2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $30.15 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $23.42 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $17.14 | 2023 | |
| Celgene Corporation | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kurz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.